For the first time, the extreme variability in dengue fever has been linked to a biological mechanism, potentially opening ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Skin study findings may help to explain why African ancestry is associated with a lower risk of severe dengue.

The gross proceeds from the Offering are approximately $19 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the ...

Northwestern Medicine investigators have identified a surprising culprit in the progression of inflammatory bowel disease: a ...

San Diego-based Capstan is developing a potential first-in-class therapy to treat certain autoimmune disease by changing ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 ...

AbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage biotechnology company Capstan Therapeutics, Inc., in a bid to boost its ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing ...